SOX9 is a regulator of ADAMTSs-induced cartilage degeneration at the early stage of human osteoarthritis

These findings indicated that SOX9 upregulation might mediate ADAMTSs suppression at the early stage of human OA. In addition, SOX9 could be used as a potential therapeutic agent for human OA at an early stage.